Hyperphagia and weight gain after gold-thioglucose: Relation to hypothalamic neuropeptide Y and proopiomelanocortin

Endocrinology

Volumn 139, Issue 11, 1998, Pages 4483-4488

  Bergen, Hugo T ^a   Mizuno, Tooru M ^b   Taylor, Jason ^a   Mobbs, Charles V ^b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUROTHIOGLUCOSE; NEUROPEPTIDE Y; PROOPIOMELANOCORTIN;

ANIMAL TISSUE; ARTICLE; FOOD INTAKE; GENE DELETION; GLUCOSE TRANSPORT; HYPERPHAGIA; HYPOTHALAMUS; MOUSE; NONHUMAN; OBESITY; PEPTIDE SYNTHESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; TARGET CELL; WEIGHT GAIN;

EID: 0031766722     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.139.11.6324     Document Type: Article

References (47)

1. Dryden S, Frankish H, Wang Q, Williams G 1994 Neuropeptide Y and energy-balance: one way ahead for the treatment of obesity? Eur J Clin Invest 24:293-308
2. Rohner-Jeanrenaud F, Cusin I, Sainsbury A, Zakrzewska KE, Jeanrenaud B 1996 The loop system between neuropeptide Y and leptin in normal and obese rodents. Horm Metab Res 28:642-648
3. Stephens TW, Basinski M, Bristow PK, Bue-Valleskey JM, Burgett SG, Craft L, Hale J, Hoffmann J, Hsiung HM, Kriauciunas A, Mackellar W, Rosteck PR, Jr, Schoner B, Smith D, Tinsley FC, Zhang X-Y, Heiman M 1995 The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature 377:530-532
4. Wilding JP, Gilbey SG, Bailey CJ, Batt RA, Williams G, Ghatei MA, Bloom SR 1993 Increased neuropeptide-Y messenger ribonucleic acid (mRNA) and decreased neurotensin mRNA in the hypothalamus of the obese (ob l ob) mouse. Endocrinology 132:1939-1944
5. Chua JSC, Brown AW, Kim J, Hennessey KL, Leibel RL, Hirsch J 1991 Food deprivation and hypothalamic neuropeptide gene expression: effects of strain background and the diabetes mutation. Mol Brain Res 11:291-299
6. Kesterson RA, Huszar D, Lynch CA, Simerly RB, Cone RD 1997 Induction of neuropeptide Y gene expression in the dorsal medial hypothalamic nucleus in two models of the agouti obesity syndrome. Mol Endocrinol 11:630-637
7. Schwartz MW, Seeley RJ, Campfield CA, Burn P, Baskin DG 1996 Identification of targets of leptin action in rat hypothalamus. J Clin Invest 98:1101-1106
8. Erickson JC, Hollopeter G, Palmiter RD 1996 Attenuation of the obesity syndrome of ob/ob mice by the loss of neuropeptide Y. Science 274:1704-1707
9. Bultman SJ, Michaud EJ, Woychik RP 1992 Molecular characterization of the mouse agouti locus. Cell 71:1195-1204
10. Miller MW, Duhl DM, Vrieling H, Cordes SP, Ollmann MM, Winkes BM, Barsh GS 1993 Cloning of the mouse agouti gene predicts a secreted protein ubiquitously expressed in mice carrying the lethal yellow mutation. Genes Dev 7:454-467
11. Klebig ML, Wilkinson JE, Geisler JG, Woychik RP 1995 Ectopic expression of the agouti gene in transgenic mice causes obesity, features of type II diabetes, and yellow fur. Proc Natl Acad Sci USA 92:4728-4732
12. Lu D, Willard D, Patel IR, Kadwell S, Overton L, Kost T, Luther M, Chen W, Woychik RP, Wilkison WO, Cone RD 1994 Agouti protein is an antagonist of the melanocyte-stimulating-hormonc receptor. Nature 371:799-802
13. Fan W, Boston BA, Kesterson RA, Hruby VJ, Cone RD 1997 Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature 385:165-168
14. Huszar D, Lynch CA, Fairchild-Huntress V, Dunmore JH, Fang Q, Berkemeier LR, Gu W, Kesterson RA, Boston BA, Cone RD, Smith FJ, Campfield LA, Burn P, Lee F 1997 Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 88:131-141
15. Tsujii S, Bray GA 1989 Acetylation alters the feeding response to MSH and β-endorphin. Brain Res Bull 23:165-169
16. Thomton JE, Cheung CC, Clifton DK, Steiner RA 1997 Regulation of hypothalamic proopiomelanocortin mRNA by leptin in ob/ob mice. Endocrinology 138:5063-5066
17. Schwartz MW, Seeley RJ, Woods SC, Weigle DS, Campfield LA, Burn P, Baskin DG 1997 Leptin increases hypothalamic pro-opiomelanocortin mRNA expression in the rostral arcuate nucleus. Diabetes 46:2119-2123
18. Mizuno TM, Kleopoulos SP, Bergen H, Roberts JL, Priest CA, Mobbs CV 1998 Hypothalamic pro-opiomelanocortin mRNA is reduced by fasting and in ob/ob and dbldb mice, but is stimulated by leptin. Diabetes 47:294-297
19. Bray GA 1984 Syndromes of hypothalamic obesity in man. Pediatr Ann 13:525-536
20. Meister B, Ceccatelli S, Hokfelt T, Anden N-E, Anden M, Theodorsson E 1989 Neurotransmitters, neuropeptides and binding sites in the rat mediobasal hypothalamus: effects of monosodium glutamate. Exp Brain Res 76:343-368
21. Debons AF, Krimsky I, Maayan ML, Fani K, Jemenez FA 1977 Gold Ihioglucose obesity syndrome. Fed Proc 36:143-147
22. Coscina DV, McArthur RA, Stancer HC, Godse DD 1978 Association of altered brain norephinephrine and serotonin with the obesity induced by goldthioglucose in mice. Pharmacol Biochem Behav 9:123-128
23. Debons AF, Siclari E, Das KC, Fuhr B 1982 Gold thioglucose-induced hypothalamic damage, hyperphagia, and obesity: dependence on the adrenal gland. Endocrinology 110:2024-2029
24. Houseknecht KL, Mantzoros CS, Kuliawat R, Hadro E, Flier JS, Kahn BB 1996 Evidence for leptin binding to proteins in serum of rodents and humans: modulation with obesity. Diabetes 45:1638-1643
25. Heydrick SJ, Gautier N, Olichon-Berthe C, Van Obberghen E, Le Marchand-Brustel Y 1995 Early alteration of insulin stimulation of PI 3-kinase in muscle and adipocyte from gold thioglucose obese mice. Am J Physiol 268:E604-E612
26. Lorden JF, Dawson Jr R, Callahan M 1979 Effects of goldthiuglucose lesions on central catecholamine levels in the mouse. Pharmacol Biochem Behav 10:165-169
27. Machado UF, Shimizu I, Saito M 1944 Reduced content and preserved translocation of glucose transporter (GLUT 4) in white adipose tissue of obese mice. Physiol Behav 55:621-625
28. Maffei M, Fei H, Lee GH, Dani C, Leroy P, Zhang Y, Proenca R, Negrel R, Ailhaud G, Friedman JM 1995 Increased expression in adipocytes of ob RNA in mice with lesions of the hypothalamus and with mutations at the db locus. Proc Natl Acad Sci USA 92:6957-6960
29. Marks JL, Waite K, Cameron-Smith D, Blair SC, Cooney GJ 1996 Effects of gold thioglucose on neuropeptide Y messenger RNA levels in the mouse hypothalamus. Am J Physiol 270:R1208-R1214
30. Pace C, Delmo C, Lee R 1989 Altered electrical responses of B-cells after goldthioglucose-induced lesions in the ventromedial hypothalamus. Res Commun Chem Pathol Pharmacol 65:401-404
31. Saito M, Bray GA 1983 Diurnal rhythm for corticosterone in obese (ob/ob), diabetes (db/db) and gold-thioglucose-induced obesity in mice. Endocrinology 113:2181-2185
32. Silva E, Hernandez L 1989 Goldthioglucose causes brain norepinephrine and serotonin depletion correlated with increased body weight. Brain Res 490:192-195
33. Brown DF, Viles JM 1982 Systemic phlorizin prevents gold thioglucose necrosis in the ventromedial hypothalamus. Brain Res Bull 8:347-351
34. Bergen HT, Monkman N, Mobbs CV 1996 Injection with gold thioglucose impairs sensitivity to glucose: evidence that glucose-responsive neurons are important for long-term regulation of body weight. Brain Res 734:332-336
35. Bergen HT, Mobbs CV 1996 Ventromedial hypothalamic lesions produced by gold thioglucose do not impair induction of NPY mRNA in the arcuate nucleus by tasting. Brain Res 707:266-271
36. Mizuno TM, Bergen H, Funabashi T, Kleopoulos SP, Zhong YG, Bauman WA, Mobbs CV 1996 Obese gene expression: reduction by fasting and stimulation by insulin and glucose in lean mice, and persistent elevation in acquired (diet-induced) and genetic (yellow agouli) obesity. Proc Natl Acad Sci USA 93:3434-3438
37. Frederich RC, Löllmann B, Hamann A, Napolitano-Rosen A, Kahn BB, Lowell BB, Flier JS 1995 Expression of ob mRNA and its encoded protein in rodents: Impact of nutrition and obesity. J Clin Invest 96:1658-1663
38. De Laey P 1975 Hypothalamic and nutritional obesities in mice. A comparative study of growth and body composition. Arch Int Pharmacodyn Ther 216:288-314
39. Cameron DP, Cutbush L, Opat F 1978 Effects of monosodium glutamate-induced obesity in mice on carbohydrate metabolism in insulin secretion. Clin Exp Pharmacol Physiol 5:41-51
40. Zhang WM, Kuchar S, Mozes S 1994 Body fat and RNA content of the VMH cells in rats neonatally treated with monosodium glutamate. Brain Res Bull 35:383-385
41. Bunyan J, Murrell EA, Shah PP 1976 The induction of obesity in rodents by means of monosodium glutamate. Br J Nutr 35:25-39
42. Erickson JC, Clegg KE, Falmiter RD 1996 Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y. Nature 381:415-418
43. Cool DR, Normant E, Shen F, Chen HC, Pannell L, Zhang Y, Loh YP 1997 Carboxypeptidase E is a regulated secretory pathway sorting receptor: genetic obliteration leads to endocrine disorders in Cpe(fat) mice. Cell 88:73-83
44. Boston BA, Blaydon KM, Varnerin J, Cone RD 1997 Independent and additive effects of central POMC and leptin pathways on murine obesity. Science 278:1641-1644
45. Nagashima K, Zabriskie JB, Lyons MJ 1992 Virus-induced obesity in mice: association with a hypothalamic lesion. J Neuropathol Exp Neurol 51:101-109
46. Good DJ, Porter FD, Mahon KA, Parlow AF, Westphal H, Kirsch IR 1997 Hypogonadism and obesity in mice with a targeted deletion of the Nlilh2 gene. Nat Genet 15:397-401
47. Krude H, Biebermann H, Luck W, Horn R, Brabant G, Gruters A 1998 Severe early-onset obesity, adrenal insufficiency, and red hair pigmentation caused by POMC mutations in humans. Nat Genet 19:155-157